SCHEMBL2379526

SCHEMBL2379526

COC[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H](OC)[C@H](COC(C)=O)OC

nearest known ligand 0.69

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.69
ABCB1 P08183 1/20 0.40
POLB P06746 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2377235 1.00 TDP1 (0.69) TDP1ABCB1POLBMAPK1
SCHEMBL10422260 1.00 TDP1 (0.69) TDP1ABCB1POLBMAPK1
SCHEMBL7788146 1.00 TDP1 (0.69) TDP1ABCB1POLBMAPK1
SCHEMBL17239682 1.00 TDP1 (0.69) TDP1ABCB1POLBMAPK1
SCHEMBL2785418 1.00 TDP1 (0.69) TDP1ABCB1POLBMAPK1
SCHEMBL2378068 1.00 TDP1 (0.69) TDP1ABCB1POLBMAPK1
SCHEMBL1581172 0.97 TDP1 (0.62) TDP1ABCB1POLBMAPK1
SCHEMBL9577881 0.97 TDP1 (0.62) TDP1ABCB1POLBMAPK1
SCHEMBL2377272 0.97 TDP1 (0.62) TDP1ABCB1POLBMAPK1
SCHEMBL20607560 0.97 TDP1 (0.73) TDP1ABCB1POLBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118702838-A Preparation method, product and application of fingered citron polysaccharide 仲恺农业工程学院 2024-09-27 CN disclosed
CN-117551213-A Golden thorn pear polysaccharide and preparation method and application thereof 贵阳学院 2024-02-13 CN disclosed
EP-1908819-B1 POLYSACCHARIDE PRODUCED BY MICROORGANISM BELONGING TO GENUS BIFIDOBACTERIUM MORISHITA JINTAN CO (JP) 2016-10-12 EP disclosed
US-20140154218-A1 ANTI-ALLERGIC AGENT MORISHITA JINTAN CO., LTD. (JP) 2014-06-05 US disclosed
EP-2551283-A1 ANTI-ALLERGIC AGENT Morishita Jintan Co., Ltd. (JP) 2013-01-30 EP disclosed
US-20130005959-A1 ANTI-ALLERGIC AGENT MORISHITA JINTAN CO., LTD. (JP) 2013-01-03 US disclosed
US-8022049-B2 Polysaccharide produced by microorganism belonging to genus Bifidobacterium MORISHITA JINTAN CO., LTD. (JP) 2011-09-20 US disclosed
US-20100174063-A1 Polysaccharide Produced by Microorganism Belonging to Genus Bifidobacterium MORISHITA JINTAN CO., LTD. (JP) 2010-07-08 US disclosed
EP-1908819-A1 POLYSACCHARIDE PRODUCED BY MICROORGANISM BELONGING TO GENUS BIFIDOBACTERIUM Morishita Jintan Co., Ltd. (JP) 2008-04-09 EP disclosed
US-5173292-A Cancer diagnosis SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1992-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140154218-A1 ANTI-ALLERGIC AGENT FUT6, GALK1, GALE TDP1 4111/4885ABCB1 3489/4885POLB 4109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.